The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
| 1 | N | Nervous system | |
| 2 | N05 | Psycholeptics | |
| 3 | N05B | Anxiolytics | |
| 4 | N05BX | Other anxiolytics | |
| 5 | N05BX03 | Etifoxine |
| Active Ingredient | Description | |
|---|---|---|
| Etifoxine |
Etifoxine is a nonbenzodiazepine anxiolytic agent and acts as a GABAA receptor positive allosteric modulator and as a ligand for translocator proteins. Both mechanisms are conjectured to contribute to its anxiolytic properties. Etifoxine primarily indicated for short-term management of adjustment disorder, specifically instances of situational depression accompanied by anxiety, such as stress-induced anxiety. |
| Title | Information Source | Document Type | |
|---|---|---|---|
| STRESAM Capsule | MPI, EU: SmPC |
Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.
